Breast Health

October 29, 2026
HHS Launches Breast Cancer Screening Initiative, Highlights Dense Tissue
October 15, 2026
BeSound Opens NYC Breast Imaging Clinic, Plans National Expansion
October 9, 2026
Feminai Pilots At-Home Breast Exam Kit With Midi Health
September 29, 2026
Breast Cancer Research Foundation Launches $100M Venture Program
September 14, 2026
FDA Approves AstraZeneca’s Etcamah for Advanced Breast Cancer
September 9, 2026
Petal Launches Bra-insert Women’s Health Wearable
September 4, 2026
Tensive Secures Up to €20M to Develop Breast Reconstruction Implant Alternative
September 3, 2026
ProvanAI Secures $1.2M to Develop Ovarian Cancer Risk Assessment
August 5, 2026
GE HealthCare Launches AI-Powered Breast Ultrasound
July 31, 2026
Astrin Biosciences Study Validates Blood Test For Early-Stage Breast Cancer Detection
July 15, 2026
FDA Approves Celcuity’s REVTORPYK for HR+/HER2-, PIK3CA Wild-Type Advanced Breast Cancer
July 13, 2026
Roche’s Genentech Signs $490M Breast Cancer Drug Discovery Deal with Astex Pharmaceuticals
July 10, 2026
Imagion Biosystems Raises AU$3.75M; Extends Siemens Partnership to Advance Breast Cancer Trial
July 7, 2026
FDA Approves Pfizer’s IBRANCE for HR+/HER2+ Metastatic Breast Cancer
July 2, 2026
Quibim Launches AI Tool for Breast Cancer Detection via MRI in Europe and the UK
June 24, 2026
Spotlight Medical Secures CE Mark for AI Breast Cancer Prognostic Test
June 10, 2026
Mammogen Raises Up to $30M for RNA Blood Test That Could Reduce Unnecessary Breast Biopsies
June 1, 2026
OPTIMA Trial Finds Gene Test Can Identify Breast Cancer Patients Who Can Safely Forgo Chemotherapy
May 26, 2026
FDA Approves DATROWAY for Triple-Negative Breast Cancer, Delivering Median Survival of Two Years
May 19, 2026
FDA Approves ENHERTU for Early Breast Cancer in Two New Indications
May 11, 2026
Artera Receives FDA Clearance for AI-Powered Breast Cancer Risk Stratification Tool
May 5, 2026
FDA Approves VEPPANU, a New Class of Targeted Therapy for Advanced Breast Cancer
April 20, 2026
ScreenPoint Medical Raises $16M to Scale AI-Powered Breast Cancer Detection Globally
March 20, 2026
Novartis Acquires Next-Generation Breast Cancer Drug in $3 Billion Deal